Your browser doesn't support javascript.
loading
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Balermpas, Panagiotis; Rödel, Franz; Krause, Mechthild; Linge, Annett; Lohaus, Fabian; Baumann, Michael; Tinhofer, Inge; Budach, Volker; Sak, Ali; Stuschke, Martin; Gkika, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Stangl, Stefan; Ganswindt, Ute; Belka, Claus; Pigorsch, Steffi; Multhoff, Gabriele; Combs, Stephanie E; Welz, Stefan; Zips, Daniel; Lim, Su Yin; Rödel, Claus; Fokas, Emmanouil.
Afiliação
  • Balermpas P; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Frankfurt, Germany.
  • Rödel F; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.
  • Krause M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Frankfurt, Germany.
  • Linge A; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.
  • Lohaus F; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Dresden, Germany.
  • Baumann M; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Tinhofer I; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Budach V; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology, Dresden, Germany.
  • Sak A; National Institute for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Stuschke M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Dresden, Germany.
  • Gkika E; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Grosu AL; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Abdollahi A; National Institute for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Debus J; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Dresden, Germany.
  • Stangl S; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Ganswindt U; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Belka C; National Institute for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Pigorsch S; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Dresden, Germany.
  • Multhoff G; Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Combs SE; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Welz S; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology, Dresden, Germany.
  • Zips D; National Institute for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Lim SY; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Berlin, Germany.
  • Rödel C; Department of Radiooncology and Radiotherapy, Charité-University Hospital Berlin, Berlin, Germany.
  • Fokas E; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites, Berlin, Germany.
Int J Cancer ; 141(3): 594-603, 2017 08 01.
Article em En | MEDLINE | ID: mdl-28480996
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Carcinoma de Células Escamosas / Infecções por Papillomavirus / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Quimiorradioterapia Adjuvante / Neoplasias de Cabeça e Pescoço Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Carcinoma de Células Escamosas / Infecções por Papillomavirus / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Quimiorradioterapia Adjuvante / Neoplasias de Cabeça e Pescoço Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article